Thiazolopyrimidine kinase inhibitors

The present invention is directed to novel thiazolopyrimidine compounds of Formula (I) or a form or composition thereof, and the use thereof as inhibitors of ATP-protein kinase interactions.

Saved in:
Bibliographic Details
Main Authors LIN RONGHUI, BINNUN EVA
Format Patent
LanguageChinese
English
Published 01.10.2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention is directed to novel thiazolopyrimidine compounds of Formula (I) or a form or composition thereof, and the use thereof as inhibitors of ATP-protein kinase interactions.
Bibliography:Application Number: CN200680036651